Canal-Garcia, E, Bosch-Amate, X, Belinchon, I, Puig, L. Nail Psoriasis. Actas Dermo-Sifiliograficas. 2022; 113(5)DOI:10.1016/j.ad.2022.01.006. PMID:35697407. IF:(Q/D).

Medrano, RM, Estebaranz, JLL, Sanmartin-Jimenez, O, Garces, JR, Rodriguez-Prieto, MA, Vilarrasa-Rull, E, De Eusebio-Murillo, E, Escutia-Munoz, B, Florez-Menendez, A, Artola-Igarza, JL, Alfaro-Rubio, A, Redondo, P, Delgado-Jimenez, Y, Sanchez-Schmidt, JM, Allende-Markixana, I, Alonso-Pacheco, ML, Garcia-Bracamonte, B, De la Cueva-Dobao, P, Navarro-Tejedor, R, Ciudad-Blanco, C, Carnero-Gonzalez, L, Vazquez-Veiga, H, Cano-Martinez, N, Ruiz-Salas, V, Sanchez-Sambucety, P, Botella-Estrada, R, Gonzalez-Sixto, B, Martorell-Calatayud, A, Gil, P, Morales-Gordillo, V, Toll-Abello, A, Ocerin-Guerra, I, Mayor-Arenal, M, Suarez-Fernandez, R, Sainz-Gaspar, L, Descalzo, MA, Garcia-Doval, I. Risk of a Second Skin Cancer in a Cohort of Patients With Nonmelanoma Skin Cancer - Basal Cell Carcinoma or Squamous Cell Carcinoma - Treated With Mohs Micrographic Surgery: A National Prospective Cohort Study. Actas Dermo-Sifiliograficas. 2022; 113(5)DOI:10.1016/j.ad.2022.01.035. PMID:. IF:(Q/D).

Blauvelt, A, Tsai, TF, Langley, RG, Miller, M, Shen, YK, You, Y, Yang, YW, Papp, KA, Puig, L. Consistent safety profile with up to 5 years of continuous treatment with guselkumab: Pooled analyses from the phase 3 VOYAGE 1 and VOYAGE 2 trials of patients with moderate-to-severe psoriasis. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2022; 86(4)DOI:10.1016/j.jaad.2021.11.004. PMID:34798201. IF:13.800(Q1/1D).

Vidal, S, Puig, L, Carrascosa-Carrillo, JM, Gonzalez-Cantero, A, Ruiz-Carrascosa, JC, Velasco-Pastor, AM. From Messengers to Receptors in Psoriasis: The Role of IL-17RA in Disease and Treatment (vol 22, 6740, 2021). INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(5)DOI:10.3390/ijms23052649. PMID:35270045. IF:5.600(Q1/3D).

Bes, M, Costafreda, MI, Riveiro-Barciela, M, Piron, M, Rico, A, Quer, J, Puig, L, Sauleda, S. Effect of Hepatitis E Virus RNA Universal Blood Donor Screening, Catalonia, Spain, 2017-2020. EMERGING INFECTIOUS DISEASES. 2022; 28(1)DOI:10.3201/eid2801.211466. PMID:34932460. IF:11.800(Q1/1D).

Gimenez-Arnau, A, Bartra, J, Ferrer, M, Jauregui, I, Borbujo, J, Figueras, I, Munoz-Bellido, F, Pedraz, J, Serra-Baldrich, E, Tejedor-Alonso, M, Velasco, M, Terradas, P, Labrador, M. A Specialized Therapeutic Approach to Chronic Urticaria Refractory to H1-Antihistamines Improves Disease Burden: The Spanish AWARE Experience. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY. 2022; 32(3)DOI:10.18176/jiaci.0661. PMID:33349612. IF:7.200(Q1/2D).

Gisondi P., Simon D., Alarcon I., Pournara E., Puig L.. Immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in patients receiving secukinumab: a literature review. JOURNAL OF DERMATOLOGICAL TREATMENT. 2023; 34(1)DOI:10.1080/09546634.2023.2167487. PMID:36625506. IF:2.900(Q2/4D).

Mateu-Arrom, L, Rusinol, L, Puig, L. Reddish and edematous nodules in an immunosuppressed patient. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2023; 62(7)DOI:10.1111/ijd.16512. PMID:36371702. IF:3.500(Q1/3D).